One NY-ESO-1-Derived Epitope That Promiscuously Binds to Multiple HLA-DR and HLA-DP4 Molecules and Stimulates Autologous CD4+ T Cells from Patients with NY-ESO-1-Expressing Melanoma-Reference-Cited by-同舟云学术

One NY-ESO-1-Derived Epitope That Promiscuously Binds to Multiple HLA-DR and HLA-DP4 Molecules and Stimulates Autologous CD4+ T Cells from Patients with NY-ESO-1-Expressing Melanoma

Published:2005-01-20 Issue:3 Volume:174 Page:1751-1759
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Mandic Maja,Castelli Florence,Janjic Bratislav,Almunia Christine,Andrade Pedro,Gillet Daniel,Brusic Vladimir,Kirkwood John M.,Maillere Bernard,Zarour Hassane M.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference22 articles.

1. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

2. Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

3. Identification of CD4+ T Cell Epitopes from NY-ESO-1 Presented by HLA-DR Molecules

4. CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A general platform for targeting MHC-II antigens via a single loop;2024-01-30

2. Characterization of genetic humanized mice with transgenic HLA DP401 or DRA but deficient in endogenous murine MHC class II genes upon Staphylococcus aureus pneumonia;Animal Models and Experimental Medicine;2023-05-29

3. Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool;Immunology;2023-04-13

4. Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatment: a case report;Journal for ImmunoTherapy of Cancer;2020-09

5. Telomerase and CD4 T Cell Immunity in Cancer;Cancers;2020-06-25